samedan logo
 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

SCORR Marketing and Applied Clinical Trials Release Report on Collaborative R&D in the Drug Development Industry

Applied Clinical Trials

Study on collaboration in the life sciences industry

Industry Kearney, Neb., Oct. 18, 2017

SCORR Marketing, a global health science marketing and communications firm, and Applied Clinical Trials have released a new study, Collaborative R&D Survey Report. The report details the extent to which collaboration in the life sciences industry occurs and provides insight into the factors that influence this collaboration.

“To fight the growing complexity and costs of drug development, drug sponsors are turning to a variety of strategies, one of which is collaborating on research and development (R&D),” said Anne-Marie Hess, senior strategic advisor at SCORR. “To help the industry better understand this strategy, we gathered information about attitudes toward collaborative R&D, its benefits and risks, which groups participate in such collaborations and why some partnerships are more productive than others.”

In addition, this report has information on why those in the industry think these arrangements are increasing, which stakeholders are more receptive to R&D partnerships and what types of medicines, therapeutic areas and medical devices will see more research and development through collaboration in the years ahead.

“Shared expertise and more efficient resource allocation were the two greatest perceived benefits of collaborative R&D,” said Lisa Henderson, group content director, Applied Clinical Trials, and Pharmaceutical Executive at UBM Americas. “What surprised us throughout the survey was the large discrepancy we found in some areas based on the respondents’ demographics — where their company was headquartered, the size of their company and their particular field.”

About SCORR Marketing
SCORR Marketing is the leading marketing and communications firm in the health sciences industry. We partner with organizations involved in global research, development and commercialization of biopharmaceutical and device products and the delivery of health care products and services. At SCORR, we achieve results for our clients by applying our proven, disciplined approach to synthesize market intelligence, strategy and creativity. We have locations across North America and Europe. For more information, visit www.scorrmarketing.com.
email lisa.henderson@ubm.com
email 485 Route 1 South Building F, Suite 210 Iselin, NJ 08830
 
Print this page
Send to a friend
   
spacer
News and Press Releases

CHDI Foundation extends collaboration with IRBM to accelerate development of Huntington’s disease therapeutics

IRBM, a global contract research organization (CRO), has strengthened its position in neurodegenerative disease research following an extension of its long-standing collaboration with CHDI Foundation, a nonprofit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that substantially improve the lives of those affected by Huntington’s disease (HD).
More info >>


White Papers

Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring

Dycem

A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
More info >>

Industry Events

Digital Medicine & Medtech Showcase 2019

8-9 January 2019, Parc 55 San Francisco - a Hilton Hotel

The Digital Medicine and Medtech Showcase is the dedicated home for the digital health and medtech communities during Biotech Showcase™ and one of the healthcare industry’s biggest weeks. Taking place January 8–9, Digital Medicine & Medtech Showcase includes two days of networking opportunities, curated presentations, specialized sessions, one-to-one meetings scheduled by partneringONE®, and full access to Biotech Showcase.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement